Back to Search Start Over

Mogamulizumab-induced interface dermatitis drug rash treated successfully with methotrexate and extracorporeal photopheresis in a patient with Sézary syndrome.

Authors :
Breen ID
Brumfiel CM
Patel MH
Rosenthal AC
Rule WG
DiCaudo DJ
Craig FE
Pittelkow MR
Mangold AR
Source :
JAAD case reports [JAAD Case Rep] 2021 Jan 12; Vol. 9, pp. 24-27. Date of Electronic Publication: 2021 Jan 12 (Print Publication: 2021).
Publication Year :
2021

Abstract

Competing Interests: Dr. Mangold currently provides scientific advisory for Eli Lilly and Kirin. Dr. Mangold is a clinical investigator at Eli Lilly, Novartis, Sun Pharmaceutical, Pfizer, Acetilion, Incyte, Corbus, MiRagen, Solagenix, and Regeneron. The rest of the authors have no conflicts to disclose.

Details

Language :
English
ISSN :
2352-5126
Volume :
9
Database :
MEDLINE
Journal :
JAAD case reports
Publication Type :
Report
Accession number :
33604439
Full Text :
https://doi.org/10.1016/j.jdcr.2020.12.035